<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36231717</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12422</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph191912422</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) is still in a global pandemic state. Some studies have reported that COVID-19 vaccines had a protective effect against long COVID. However, the conclusions of the studies on the effect of COVID-19 vaccines on long COVID were not consistent. This study aimed to systematically review relevant studies in the real world, and performed a meta-analysis to explore the relationship between vaccination and long COVID. We systematically searched PubMed, Embase, Web of science, and ScienceDirect from inception to 19 September 2022. The PICO (P: patients; I: intervention; C: comparison; O: outcome) was as follows: patients diagnosed with COVID-19 (P); vaccination with COVID-19 vaccines (I); the patients were divided into vaccinated and unvaccinated groups (C); the outcomes were the occurrence of long COVID, as well as the various symptoms of long COVID (O). A fixed-effect model and random-effects model were chosen based on the heterogeneity between studies in order to pool the effect value. The results showed that the vaccinated group had a 29% lower risk of developing long COVID compared with the unvaccinated group (RR = 0.71, 95% CI: 0.58-0.87, <i>p</i> &lt; 0.01). Compared with patients who were not vaccinated, vaccination showed its protective effect in patients vaccinated with two doses (RR = 0.83, 95% CI: 0.74-0.94, <i>p</i> &lt; 0.01), but not one dose (RR = 0.83, 95% CI: 0.65-1.07, <i>p</i> = 0.14). In addition, vaccination was effective against long COVD in patients either vaccinated before SARS-CoV-2 infection/COVID-19 (RR = 0.82, 95% CI: 0.74-0.91, <i>p</i> &lt; 0.01) or vaccinated after SARS-CoV-2 infection/COVID-19 (RR = 0.83, 95% CI: 0.74-0.92, <i>p</i> &lt; 0.01). For long COVID symptoms, vaccination reduced the risk of cognitive dysfunction/symptoms, kidney diseases/problems, myalgia, and sleeping disorders/problems sleeping. Our study shows that COVID-19 vaccines had an effect on reducing the risk of long COVID in patients vaccinated before or after SARS-CoV-2 infection/COVID-19. We suggest that the vaccination rate should be improved as soon as possible, especially for a complete vaccination course. There should be more studies to explore the basic mechanisms of the protective effect of COVID-19 vaccines on long COVID in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Xueyuan Road No. 38, Haidian District, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jue</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1938-9365</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Xueyuan Road No. 38, Haidian District, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Global Health and Development, Peking University, Yiheyuan Road No. 5, Haidian District, Beijing 100871, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Min</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5059-3743</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Xueyuan Road No. 38, Haidian District, Beijing 100191, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36231717</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pii">ijerph191912422</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 1 September 2022)].  31 August 2022. Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaskandan H., Nimmo A., Savino M., Afuwape S., Brand S., Graham-Brown M., Medcalf J., Cockwell P., Beckwith H. Burnout and long COVID among the UK nephrology workforce: Results from a national survey investigating the impact of COVID-19 on working lives. Clin. Kidney J. 2021;15:517&#x2013;526. doi: 10.1093/ckj/sfab264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfab264</ArticleId><ArticleId IdType="pmc">PMC8754810</ArticleId><ArticleId IdType="pubmed">35198158</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldetsadik A.Y., Abayneh M., Abraha M., Betizazu S.S., Bekele D. Clinical Characteristics and Outcome of Pediatric COVID-19 Patients in Ethiopia During the Early COVID-19 Pandemic: A Prospective Cohort Study. Pediatr. Health Med. Ther. 2022;13:165&#x2013;174. doi: 10.2147/PHMT.S359333.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PHMT.S359333</ArticleId><ArticleId IdType="pmc">PMC9106426</ArticleId><ArticleId IdType="pubmed">35573390</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sire A., Moggio L., Marotta N., Agostini F., Tasselli A., Ferrante V.D., Curci C., Calafiore D., Ferraro F., Bernetti A., et al. Impact of Rehabilitation on Fatigue in Post-COVID-19 Patients: A Systematic Review and Meta-Analysis. Appl. Sci. 2022;12:8593. doi: 10.3390/app12178593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app12178593</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Coronavirus Disease (COVID-19): Post COVID-19 Condition.  [(accessed on 1 September 2022)].  16 December 2021. Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-post-covid-19-condition.</Citation></Reference><Reference><Citation>Ayoubkhani D., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Risk of Long COVID in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: Community-based, matched cohort study. medRxiv. 2022. preprints .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.23.22271388</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021.  [(accessed on 1 September 2022)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Emecen A.N., Keskin S., Turunc O., Suner A.F., Siyve N., Sensoy E.B., Dinc F., Kilinc O., Oguz V.A., Bayrak S., et al. The presence of symptoms within 6 months after COVID-19: A single-center longitudinal study. Ir. J. Med. Sci. 2022 doi: 10.1007/s11845-022-03072-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-022-03072-0</ArticleId><ArticleId IdType="pmc">PMC9205653</ArticleId><ArticleId IdType="pubmed">35715663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P., Ssentongo A.E., Voleti N., Groff D., Sun A., Ba D.M., Nunez J., Parent L.J., Chinchilli V.M., Paules C.I. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: A systematic review and meta-analysis. BMC Infect. Dis. 2022;22:439. doi: 10.1186/s12879-022-07418-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07418-y</ArticleId><ArticleId IdType="pmc">PMC9077344</ArticleId><ArticleId IdType="pubmed">35525973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C., Shao W., Chen X., Zhang B., Wang G., Zhang W. Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis. Int. J. Infect. Dis. 2021;114:252&#x2013;260. doi: 10.1016/j.ijid.2021.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Cai S., Liu Q., Du M., Liu J., Liu M. Effectiveness and Safety of SARS-CoV-2 Vaccines among Children and Adolescents: A Systematic Review and Meta-Analysis. Vaccines. 2022;10:421. doi: 10.3390/vaccines10030421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10030421</ArticleId><ArticleId IdType="pmc">PMC8953823</ArticleId><ArticleId IdType="pubmed">35335053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr N.M., Plumb I.D., Harland K.K., Pilishvili T., Flemming-Dutra K.E., Krishnadasan A., Hoth K.F., Saydah S.H., Mankoff Z., Haran J.P., et al. Presence of Symptoms 6 Weeks after COVID-19 among Vaccinated and Unvaccinated U.S. Healthcare Personnel. medRxiv. 2022. preprints .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9895915</ArticleId><ArticleId IdType="pubmed">36731936</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., van Willigen H.D., Verveen A., Lebbink R., van der Straten K., Kootstra N., van Gils M.J., Russell C., et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine. 2022;40:4424&#x2013;4431. doi: 10.1016/j.vaccine.2022.05.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Impact of COVID-19 vaccination on long COVID: A systematic review and meta-analysis. medRxiv. 2022. preprints .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.20.22276621</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Shea B., O&#x2019;Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses.  [(accessed on 30 June 2022)].  Available online:  https://www.ohri.ca//programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Rostom A., Dub&#xe9; C., Cranney A., Saloojee N., Sy R., Mack D., Patel D., McNeal J., Moher D., Garrity C., et al.  Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 Sep. (Evidence Reports/Technology Assessments, No. 104.) Appendix D. Quality Assessment Forms.  [(accessed on 24 May 2022)];2004  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK35156/</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Salamun J., Jacquerioz F., Courvoisier D.S., Spechbach H., Guessous I. Symptoms After COVID-19 Vaccination in Patients with Post-Acute Sequelae of SARS-CoV-2. J. Gen. Intern. Med. 2022;37:1585&#x2013;1588. doi: 10.1007/s11606-022-07443-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07443-2</ArticleId><ArticleId IdType="pmc">PMC8863092</ArticleId><ArticleId IdType="pubmed">35194744</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi H.Y., Alrashed A.M., Jawhari A.M., Abdel-Moneim A.S. Neuropsychiatric symptoms in post-COVID-19 long haulers. Acta Neuropsychiatr. 2022. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2022.13</ArticleId><ArticleId IdType="pubmed">35543105</ArticleId></ArticleIdList></Reference><Reference><Citation>El Otmani H., Nabili S., Berrada M., Bellakhdar S., El Moutawakil B., Abdoh Rafai M. Prevalence, characteristics and risk factors in a Moroccan cohort of Long-COVID-19. Neurol. Sci. 2022;43:5175&#x2013;5180. doi: 10.1007/s10072-022-06138-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06138-0</ArticleId><ArticleId IdType="pmc">PMC9132567</ArticleId><ArticleId IdType="pubmed">35614173</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>De Arriba Fern&#xe1;ndez A., Alonso Bilbao J.L., Espi&#xf1;eira Franc&#xe9;s A., Cabeza Mora A., Guti&#xe9;rrez P&#xe9;rez &#xc1;., D&#xed;az Barreiros M.&#xc1;., Serra Majem L. Assessment of SARS-CoV-2 Infection According to Previous Metabolic Status and Its Association with Mortality and Post-Acute COVID-19. Nutrients. 2022;14:2925. doi: 10.3390/nu14142925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14142925</ArticleId><ArticleId IdType="pmc">PMC9325256</ArticleId><ArticleId IdType="pubmed">35889880</ArticleId></ArticleIdList></Reference><Reference><Citation>Messiah S.E., Hao T., DeSantis S.M., Swartz M.D., Talebi Y., Kohl H.W., III, Zhang S., Valerio-Shewmaker M., Yaseen A., Kelder S.H., et al. Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents. Pediatr. Infect. Dis. J. 2022. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003653</ArticleId><ArticleId IdType="pubmed">35939608</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza-Torres B., Delanerolle G., Okusi C., Mayer N., Anand S., McCartney J., Gatenby P., Glampson B., Chapman M., Curcin V., et al. Differences in clinical presentation with long COVID following community and hospital infection, and associations with all-cause mortality: English sentinel network database study (Preprint) JMIR Public Health Surveill. 2022;8:e37668. doi: 10.2196/37668.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37668</ArticleId><ArticleId IdType="pmc">PMC9384859</ArticleId><ArticleId IdType="pubmed">35605170</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M., De Martino M., Palese A., Gerussi V., Bontempo G., Graziano E., Visintini E., D&#x2019;Elia D., Dellai F., Marrella F., et al. Post&#x2013;COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clin. Microbiol. Infect. 2022;28:1140&#x2013;1148. doi: 10.1016/j.cmi.2022.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.03.016</ArticleId><ArticleId IdType="pmc">PMC8940723</ArticleId><ArticleId IdType="pubmed">35339673</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinato D.J., Ferrante D., Aguilar-Company J., Bower M., Salazar R., Mirallas O., Sureda A., Bertuzzi A., Brunet J., Lambertini M., et al. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. Eur. J. Cancer. 2022;171:64&#x2013;74. doi: 10.1016/j.ejca.2022.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2022.04.036</ArticleId><ArticleId IdType="pmc">PMC9124924</ArticleId><ArticleId IdType="pubmed">35704976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis S.N., Durieux J.C., Mouchati C., Perez J.A., McComsey G.A. The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network. Open Forum Infect. Dis. 2022;9:ofac228. doi: 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjaji N., Lepoutre K., Lakhdar S., B&#xe9;court S., Bellier C., Kaczmarek E., Broyelle A., Giscard S., Lartigau E. 16 Months Follow Up of Patients&#x2019; Behavior and Mild COVID-19 Patterns in a Large Cohort of Cancer Patients During the Pandemic. Front. Oncol. 2022;12:901426. doi: 10.3389/fonc.2022.901426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.901426</ArticleId><ArticleId IdType="pmc">PMC9209649</ArticleId><ArticleId IdType="pubmed">35747798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Gorelik Y., Zayyad H., Wertheim O., Wiegler K.B., Abu Jabal K., Dror A.A., Nazzal S., Glikman D., Edelstein M. Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: Cross-sectional study 2020-21, Israel. npj Vaccines. 2022;7:101. doi: 10.1038/s41541-022-00526-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon M.A., Luginbuhl R.D., Parker R. Reduced incidence of long-COVID symptoms related to administration of COVID-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after. medRxiv. 2021 doi: 10.1101/2021.11.17.21263608. preprints .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.17.21263608</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhiraja S., Indrayan A., Mahajan M. Effect of COVID-19 vaccine on long-COVID: A 2-year followup observational study from hospitals in north India. medRxiv. 2022. preprints .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.18.22277740</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 24 September 2022)].  11 November 2021. Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Liu Q., Qin C., Liu M., Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: A systematic review and meta-analysis. Infect. Dis. Poverty. 2021;10:132. doi: 10.1186/s40249-021-00915-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-021-00915-3</ArticleId><ArticleId IdType="pmc">PMC8590867</ArticleId><ArticleId IdType="pubmed">34776011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow C.S., Hasan S.S. Real-world effectiveness of BNT162b2 mRNA vaccine: A meta-analysis of large observational studies. Inflammopharmacology. 2021;29:1075&#x2013;1090. doi: 10.1007/s10787-021-00839-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00839-2</ArticleId><ArticleId IdType="pmc">PMC8266992</ArticleId><ArticleId IdType="pubmed">34241782</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreen S., Chung H., He S., Brown K.A., Gubbay J.B., Buchan S.A., Fell D.B., Austin P.C., Schwartz K.L., Sundaram M.E., et al. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat. Microbiol. 2022;7:379&#x2013;385. doi: 10.1038/s41564-021-01053-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-01053-0</ArticleId><ArticleId IdType="pubmed">35132198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of long COVID symptoms after COVID-19 vaccination: Community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L.G., Paleoudis E.G., Bari D.L.-D., Nyirenda T., Friedman T., Gupta A., Rasouli L., Zetkulic M., Balani B., Ogedegbe C., et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS ONE. 2020;15:e0243882. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O&#x2019;Hara M.E., Hastie C., Roderick P., Yao G., Alwan N.A. Characteristics and impact of Long COVID: Findings from an online survey. PLoS ONE. 2022;17:e0264331. doi: 10.1371/journal.pone.0264331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Suyanto S., Kandel S., Kemal R.A., Arfianti A. The Quality of Life of Coronavirus Disease Survivors Living in Rural and Urban Area of Riau Province, Indonesia. Infect. Dis. Rep. 2022;14:33&#x2013;42. doi: 10.3390/idr14010005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr14010005</ArticleId><ArticleId IdType="pmc">PMC8788287</ArticleId><ArticleId IdType="pubmed">35076531</ArticleId></ArticleIdList></Reference><Reference><Citation>Boaventura P., Macedo S., Ribeiro F., Jaconiano S., Soares P. Post-COVID-19 Condition: Where Are We Now? Life. 2022;12:517. doi: 10.3390/life12040517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12040517</ArticleId><ArticleId IdType="pmc">PMC9029703</ArticleId><ArticleId IdType="pubmed">35455008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Kream R.M., Stefano G.B. Long-Term Respiratory and Neurological Sequelae of COVID-19. Med. Sci. Monit. 2020;26:e928996. doi: 10.12659/MSM.928996.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.928996</ArticleId><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., de Noordhout C.M., Jong C.P.-D., Cleemput I., Heede K.V.D. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Greenhalgh T., Milne R., Delaney B. Are vaccines a potential treatment for long covid? BMJ. 2022;377:o988. doi: 10.1136/bmj.o988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o988</ArticleId><ArticleId IdType="pubmed">35584848</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G., Diodati F., Puntoni M., Lazzarelli S., Marcomini B., Patrizi L., Caminiti C. Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaksi N., Teker A.G., Imre A. Long COVID in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. Iran. J. Public Health. 2022;51:88&#x2013;95. doi: 10.18502/ijph.v51i1.8297.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijph.v51i1.8297</ArticleId><ArticleId IdType="pmc">PMC8837882</ArticleId><ArticleId IdType="pubmed">35223629</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Felten R., Gallais F., Nazon C., Chatelus E., Pijnenburg L., Mengin A., Gras A., Vidailhet P., Arnould-Michel R., et al. Refining &#x201c;Long-COVID&#x201d; by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection. Infect. Dis. Ther. 2021;10:1747&#x2013;1763. doi: 10.1007/s40121-021-00484-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-021-00484-w</ArticleId><ArticleId IdType="pmc">PMC8270770</ArticleId><ArticleId IdType="pubmed">34245450</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. Do vaccines protect from long COVID? Lancet Respir. Med. 2022;10:E30. doi: 10.1016/S2213-2600(22)00020-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00020-0</ArticleId><ArticleId IdType="pmc">PMC8776281</ArticleId><ArticleId IdType="pubmed">35065716</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>